Read More Pharma Industry News What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC Could TN-401 reshape inherited heart disease treatment? Explore what Tenaya Therapeutics, Inc.’s RIDGE-1 data means for cardiac gene therapy. bySoujanya RaviMay 17, 2026